Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: A structured summary of a study protocol for a randomised controlled trial
Vergis N,
Phillips R,
Cornelius V,
Katsarou A,
Youngstein T,
Cook L,
Willicombe M,
Pilay C,
Shturova T,
Almonte M,
Charania A,
Turner R,
Kon OM,
Cooke G,
Thursz M,
Cherlin S,
Wason J,
Milojkovic D,
Innes AJ,
Cooper N April 2021Publication
Trials 2021; 22:270